Trade Mark Journal No.2026/007 13 February 2026

WO0000001887021 (36,41,44)

Office of origin: Switzerland

Date of International Registration:28 August 2025
Date of designation in the UK: 28 August 2025
Image for mark 1887021

The mark contains the colours blue and red.

International priority date claimed: 14 August 2025 (Switzerland)
Class 36
Financial sponsorship of development projects for the purpose of enhancing care for persons with haemophilia and haemoglobinopathies; charitable fund raising to promote public awareness of haemophilia and haemoglobinopathies.
Class 41
Training services, namely, training services for health care staff and persons with haemophilia and haemoglobinopathies and members of their families; Training services in connection with the implementation of medical care guidelines; training services for promoting awareness of haemophilia and haemoglobinopathies.
Class 44
Medical diagnosis, care, and treatment of persons with haemophilia and haemoglobinopathies.

Novo Nordisk Haemophilia & Haemoglobinopathies Foundation

Representative: Isler & Pedrazzini AG, Postfach, CH-8027 Zürich, SWITZERLAND